Target intelligence / Profile preview

microRNA 548ap (MIR548AP)

Target
MIR548AP
Molecular classification
MicroRNA, Non-coding RNA, Repetitive element (RE)-derived microRNA, Primate-specific microRNA
01

Overview

microRNA 548ap (MIR548AP) is a small, non-coding RNA molecule that belongs to the miR-548 family, which is derived from repetitive elements within the genome (notably, the MITE repetitive element MADE1)[1]. It is primate-specific and is one of a large, evolutionarily divergent family of miRNAs found primarily in primate genomes[1]. MIR548AP, like other microRNAs, is believed to regulate gene expression at the posttranscriptional level by binding to target mRNAs, which can result in mRNA degradation or inhibition of translation[2]. While the general role of microRNAs includes regulation of key cellular processes such as differentiation, proliferation, apoptosis, and development, the specific biological or pathological roles of MIR548AP have not been characterized in the scientific literature[2]. No drugs or therapeutic agents are reported to directly target or utilize MIR548AP as a biomarker, and it is not specifically recognized as a molecular target in therapeutic development.

Other names
hsa-mir-548apMIR548APhsa-miR-548ap
02

Mechanism of action

Not applicable (no known targeted drugs; in general, microRNAs act via mRNA binding and regulation)

03

Biological functions

Posttranscriptional gene regulationLikely roles in cell differentiation and proliferation, based on general microRNA functionsEvolutionary diversification of gene regulation in primatesOther (specific biological pathways for MIR548AP remain undefined in current literature)
04

Disease associations

Other (no specific, direct disease association for MIR548AP identified in current literature for cancer, inflammation, etc.)Potential for involvement in disease given general microRNA activities, but not specifically established for MIR548AP
05

Safety considerations

None reported (therapeutic targeting or modulation not established for this microRNA)
06

Interacting drugs

None known (no drugs identified to specifically interact with MIR548AP)
07

Biomarkers

None established (no evidence that MIR548AP is an established disease or therapy biomarker)

Beyond the preview

Go deeper on microRNA 548ap (MIR548AP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 548ap (MIR548AP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call